Open AccessMuLBSTA score in COVID-19 pneumonia and prediction of 14.day mortality risk: A study in an Indian cohort
Author(s) -
Mukul Preetam,
Aditya Anurag
Publication year - 2021
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_1766_20
Subject(s) - medicine , asymptomatic , pneumonia , pandemic , covid-19 , cohort , disease , population , severity of illness , cohort study , coronavirus , pediatrics , emergency medicine , intensive care medicine , infectious disease (medical specialty) , environmental health
The infectious agent which has caused the COVID-19 pandemic is a coronavirus named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). On one end of the spectrum, a patient suffering from COVID-19 may be asymptomatic or have mild symptoms, while on the other end of the spectrum, a patient may develop numerous life-threatening complications. The way a host responds to infection by SARS-CoV-2 depends on various host factors like hypertension, old age, etc., The MuLBSTA scoring system takes into account various clinical and laboratory parameters and tries to predict the mortality risk for a patient. Besides, the validation of MuLBSTA score for mortality because of COVID-19 has not been extensively studied in an Indian set-up. This study is aimed at finding the association between the MuLBSTA score and the 14-day mortality risk because of COVID-19 in Indian population.